DragonFly EU Pivotal Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 168 participants.

Also called NCT05927441

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 168 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05927441
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Germany (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05927441. Non-randomized; no masking; primary purpose treatment. Start 2024-01-01 (actual); primary completion 2026-04-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
DragonFly EU Pivotal Study
Condition
Mitral Valve Insufficiency
Intervention (Device)
DragonFly Transcatheter Mitral Valve Repair System
Lead sponsor
Hangzhou Valgen Medtech Co., Ltd (class: industry)
Collaborator
Donawa Lifescience Consulting S.r.l. (class: industry)

Record details

Record id
cardio:ct-nct05927441
Content hash
26e4c48147ff3ea5f2498b89dcfe7889a3dc3d7d0311ee9aad0921396e55c03e